Photocure ASA (0IMT) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Photocure Asa.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04224-adf2-7e03-84e3-7aae8b1f887c Created: 2026-08-27T07:34:58.754Z Duration: 2886.0864 Channels: 1 00:00:00.000 -- 00:00:03.520 Well, good afternoon. Good morning. I'm Dan Schneider, 00:00:03.520 -- 00:00:05.759 president and CEO of Photocure. Welcome to today's 00:00:05.759 -- 00:00:06.560 presentation 00:00:06.799 -- 00:00:09.440 of second quarter twenty twenty six results. 00:00:09.679 -- 00:00:11.679 With me today is Priyam Shah, our vice 00:00:11.679 -- 00:00:14.335 president of Investor Relations, and Dick Peters, our 00:00:14.335 -- 00:00:17.295 Vice President of Finance and IT. 00:00:19.455 -- 00:00:21.935 Just a reminder that the usual disclaimers are 00:00:21.935 -- 00:00:23.695 in effect for today's presentation. 00:00:26.380 -- 00:00:28.539 So the slide you've seen before, this is 00:00:28.539 -- 00:00:31.900 Photocure's corporate strategy. It's centered on three priorities 00:00:31.900 -- 00:00:34.780 that guide execution and capital allocation. 00:00:35.340 -- 00:00:38.059 First is strengthening the core, drive disciplined growth 00:00:38.059 -- 00:00:39.579 in hex, fix, and syssue 00:00:40.035 -- 00:00:43.235 franchise by expanding blue light cystoscopy tower 00:00:43.395 -- 00:00:44.355 installations, 00:00:44.675 -- 00:00:45.475 upgrades, 00:00:45.795 -- 00:00:48.995 and The US mobile VLC adoption while increasing 00:00:48.995 -- 00:00:50.995 penetration across key markets. 00:00:51.475 -- 00:00:54.740 The second is leading the standard. Established BLC 00:00:54.900 -- 00:00:57.140 as a standard of care across non muscle 00:00:57.140 -- 00:01:01.140 invasive bladder cancer detection, surveillance and treatment monitoring 00:01:01.220 -- 00:01:04.660 through next generation high def system...